Ho-Sheng Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ho-Sheng Lin has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
Adam J. Folbe
Department of Otolaryngology–Head & Neck Surgery Wayne State University and Karmanos Cancer Institute Detroit Michigan U.S.A
7 shared publicationsGeorge H. Yoo
Department of Otolaryngology–Head & Neck Surgery Wayne State University and Karmanos Cancer Institute Detroit Michigan U.S.A
5 shared publicationsJames A. Rowley
Division of Pulmonary Critical Care and Sleep Medicine Department of Medicine Wayne State University Detroit Michigan U.S.A
5 shared publications- Wei Chen
Karmanos Cancer Institute, 4100 John R, Detroit, MI 48201, USA
4 shared publications M. Safwan Badr
Department of Medicine John D. Dingell VA Medical Center Detroit Michigan U.S.A
3 shared publicationsAbhishek S. Prasad
Department of Otolaryngology‐Head and Neck Surgery John D. Dingell VA Medical Center Detroit MI
2 shared publications
Latest Publications
- Open Access
- 1 June 2017
- Published by Wiley in World Journal of Otorhinolaryngology - Head and Neck Surgery
- Vol. 3 (2) , 79-84
OSA treatment history in an upper airway stimulation trial cohort
Objectives: Analyze the obstructive sleep apnea (OSA) treatment history in a group of participants who enrolled in a hypoglossal nerve stimulation trial.Methods: Moderate‐severe OSA patients with difficulty adhering to CPAP presented for enrollment in a multicenter trial. Self‐reported history on prior OSA medical therapy was collected at enrollment, including OSA diagnosis date, CPAP start and stop dates, oral appliance trial, and reasons for discontinuation or non‐adherence.Results: The cohort consisted of 929 participants, 83% male, with a mean age (53.9 ± 10.5) years. Ninety percent (n = 835) had complete CPAP information including 47% (n = 435) who discontinued therapy prior to enrollment and 43% (n = 400) who were still attempting CPAP but had inadequate adherence. Abandonment rates were 60% at 1‐year, 73% at 3‐years, and 86% at 5‐years. Oral appliance therapy was attempted by 171 patients for mean (1.8 ± 2.3) years, with 81% abandonment at 1 year, 89% at 3‐years, and 94% at 5‐years.Conclusions: In this CPAP‐refractory cohort, high rates of CPAP abandonment were reported in the first several years with approximately half of the participants not receiving any treatment despite being diagnosed for >5 years. Close clinical follow‐up and consideration of alternative treatment options is indicated in all OSA patients in order to ensure adequate longitudinal care.
- 1 June 2017
- Published by Wiley in World Journal of Otorhinolaryngology - Head and Neck Surgery
- Vol. 3 (2) , 79-84
Open AccessOSA treatment history in an upper airway stimulation trial cohort
Objectives: Analyze the obstructive sleep apnea (OSA) treatment history in a group of participants who enrolled in a hypoglossal nerve stimulation trial.Methods: Moderate‐severe OSA patients with difficulty adhering to CPAP presented for enrollment in a multicenter trial. Self‐reported history on prior OSA medical therapy was collected at enrollment, including OSA diagnosis date, CPAP start and stop dates, oral appliance trial, and reasons for discontinuation or non‐adherence.Results: The cohort consisted of 929 participants, 83% male, with a mean age (53.9 ± 10.5) years. Ninety percent (n = 835) had complete CPAP information including 47% (n = 435) who discontinued therapy prior to enrollment and 43% (n = 400) who were still attempting CPAP but had inadequate adherence. Abandonment rates were 60% at 1‐year, 73% at 3‐years, and 86% at 5‐years. Oral appliance therapy was attempted by 171 patients for mean (1.8 ± 2.3) years, with 81% abandonment at 1 year, 89% at 3‐years, and 94% at 5‐years.Conclusions: In this CPAP‐refractory cohort, high rates of CPAP abandonment were reported in the first several years with approximately half of the participants not receiving any treatment despite being diagnosed for >5 years. Close clinical follow‐up and consideration of alternative treatment options is indicated in all OSA patients in order to ensure adequate longitudinal care.
- Open Access
- 15 November 2016
- Published by BMJ in Journal for ImmunoTherapy of Cancer
- Vol. 4 (1) , 83
PD1/PD-L1 inhibition as a potential radiosensitizer in head and neck squamous cell carcinoma: a case report
Background Immunotherapy targeting the checkpoint PD1 (programmed cell death protein 1) or PDL1 (programmed death ligand 1) has led to advances in the treatment of melanoma and non-small cell lung cancer (NSCLC). The use of such therapies has also been introduced into the treatment of other malignancies, including head and neck cancer. The combined effects of checkpoint inhibitors and anti-PD1(L1) antibodies and radiation therapy have not yet been sufficiently investigated. Case presentation We report a case of locally relapsed non-resectable oral cavity squamous cell carcinoma, with excellent local control after pembrolizumab (MK3475) followed by radiotherapy. Conclusion T cell activation induced by checkpoint inhibition may dramatically improve tumor response to radiation. More data are needed to identify the toxicity and efficacy of sequential or concurrent checkpoint inhibitors and radiotherapy.
- 15 November 2016
- Published by BMJ in Journal for ImmunoTherapy of Cancer
- Vol. 4 (1) , 83
Open AccessPD1/PD-L1 inhibition as a potential radiosensitizer in head and neck squamous cell carcinoma: a case report
Background Immunotherapy targeting the checkpoint PD1 (programmed cell death protein 1) or PDL1 (programmed death ligand 1) has led to advances in the treatment of melanoma and non-small cell lung cancer (NSCLC). The use of such therapies has also been introduced into the treatment of other malignancies, including head and neck cancer. The combined effects of checkpoint inhibitors and anti-PD1(L1) antibodies and radiation therapy have not yet been sufficiently investigated. Case presentation We report a case of locally relapsed non-resectable oral cavity squamous cell carcinoma, with excellent local control after pembrolizumab (MK3475) followed by radiotherapy. Conclusion T cell activation induced by checkpoint inhibition may dramatically improve tumor response to radiation. More data are needed to identify the toxicity and efficacy of sequential or concurrent checkpoint inhibitors and radiotherapy.
- 2 September 2016
- Published by Springer Nature
- p. 63-69
Transoral Robotic Surgery as Single Level Surgery for Treatment of Obstructive Sleep Apnea
- 2 September 2016
- Published by Springer Nature
- p. 63-69
Transoral Robotic Surgery as Single Level Surgery for Treatment of Obstructive Sleep Apnea
- 30 May 2016
- Published by Wiley in The Laryngoscope
- Vol. 127 (1) , 110-115
Establishing a danger zone: An anatomic study of the lingual artery in base of tongue surgery
Objectives/Hypothesis To contrast the changes in measurement of the hypoglossal/lingual artery neurovascular bundle (HLNVB) to constant surface landmarks in the base of tongue (BOT) during surgically simulated retraction versus resting anatomic position, and to identify a safe zone for BOT robotic surgery to avoid injury to the HLNVB. Study Design Human cadaver study. Methods Five fresh-frozen head and neck complexes were obtained, and seven HLNVBs were dissected. A microcaliper was used to measure the distance from the HLNVB to constant surface landmarks in resting and surgically simulated positions using a Feyh-Kastenbauer retractor. Results Measurements from foramen cecum to palatoglossus muscle (P < 0.042) was significantly different when comparing anatomical to surgically simulated positions. Importantly, the location of the lingual artery in reference to the surface landmarks measured was dramatically altered with tongue retraction. With retraction, the branches of the dorsal lingual artery were not encountered posterior to a horizontal line between midway circumvallate papilla (mCVP). Conclusion Measurements of the HLNVB to surface landmarks in the BOT differs significantly between resting and a surgically simulated tongue position. The dorsal branch of the lingual artery seems more superficial in the BOT than previously described. A safe zone may exist posterior to an imaginary horizontal line between mCVP; however, further studies are needed to confirm this. Level of Evidence NA Laryngoscope, 127:110–115, 2017
- 30 May 2016
- Published by Wiley in The Laryngoscope
- Vol. 127 (1) , 110-115
Establishing a danger zone: An anatomic study of the lingual artery in base of tongue surgery
Objectives/Hypothesis To contrast the changes in measurement of the hypoglossal/lingual artery neurovascular bundle (HLNVB) to constant surface landmarks in the base of tongue (BOT) during surgically simulated retraction versus resting anatomic position, and to identify a safe zone for BOT robotic surgery to avoid injury to the HLNVB. Study Design Human cadaver study. Methods Five fresh-frozen head and neck complexes were obtained, and seven HLNVBs were dissected. A microcaliper was used to measure the distance from the HLNVB to constant surface landmarks in resting and surgically simulated positions using a Feyh-Kastenbauer retractor. Results Measurements from foramen cecum to palatoglossus muscle (P < 0.042) was significantly different when comparing anatomical to surgically simulated positions. Importantly, the location of the lingual artery in reference to the surface landmarks measured was dramatically altered with tongue retraction. With retraction, the branches of the dorsal lingual artery were not encountered posterior to a horizontal line between midway circumvallate papilla (mCVP). Conclusion Measurements of the HLNVB to surface landmarks in the BOT differs significantly between resting and a surgically simulated tongue position. The dorsal branch of the lingual artery seems more superficial in the BOT than previously described. A safe zone may exist posterior to an imaginary horizontal line between mCVP; however, further studies are needed to confirm this. Level of Evidence NA Laryngoscope, 127:110–115, 2017
- 24 October 2014
- Published by Wiley in The Laryngoscope
- Vol. 125 (4) , 1013-1020
Transoral robotic surgery for treatment of obstructive sleep apnea: Factors predicting surgical response
Objectives/Hypothesis: We reviewed our experience with the use of transoral robotic surgery (TORS) for base of tongue (BOT) reduction either alone or as part of multilevel strategy in the treatment of obstructive sleep apnea/hypopnea syndrome (OSAHS) in order to identify clinical characteristics that may be associated with surgical response.Study Design: Case series.Methods: Between June 2010 and May 2014, BOT reduction via TORS ± partial epiglottectomy ± uvulopalatopharyngoplasty were performed on 72 patients with OSAHS. Thirty‐nine patients (15 females and 24 males) with complete preoperative and postoperative clinical information including polysomnograms were included in this study.Results: Mean apnea‐hypopnea index (AHI) was 43.9 ± 32.3 preoperatively and 21.9 ± 23.5 postoperatively and reflected a statistically significant (P < 0.001) AHI reduction of 50.9% ± 38.1%. Statistical significant reduction in daytime somnolence, as measured by Epworth Sleepiness Scale (15.6 ± 5.4 preoperatively vs. 5.7 ± 4.3 postoperatively; P < 0.001), was also achieved. No statistical significant difference was found between preoperative and postoperative body mass index (BMI) (32.9 ± 7.0 vs. 32.4 ± 7.3; P = 0.270). Surgical response, as defined by > 50% reduction in AHI and final AHI < 15 with resolution of daytime somnolence, was achieved in 21 patients (53.8%). Clinical characteristics found to be significantly different between the responders and nonresponders were BMI, AHI, and lateral velopharyngeal collapse. Patients with BMI < 30, AHI < 60, or absence of lateral velopharyngeal collapse have excellent surgical response rate of 88.2%, 67.9%, or 66.7%, respectively.Conclusions: We identified three clinical characteristics associated with increased surgical response rate. This finding may be useful for patient selection and counseling prior to surgery.Level of Evidence: 4. Laryngoscope, 125:1013–1020, 2015
- 24 October 2014
- Published by Wiley in The Laryngoscope
- Vol. 125 (4) , 1013-1020
Transoral robotic surgery for treatment of obstructive sleep apnea: Factors predicting surgical response
Objectives/Hypothesis: We reviewed our experience with the use of transoral robotic surgery (TORS) for base of tongue (BOT) reduction either alone or as part of multilevel strategy in the treatment of obstructive sleep apnea/hypopnea syndrome (OSAHS) in order to identify clinical characteristics that may be associated with surgical response.Study Design: Case series.Methods: Between June 2010 and May 2014, BOT reduction via TORS ± partial epiglottectomy ± uvulopalatopharyngoplasty were performed on 72 patients with OSAHS. Thirty‐nine patients (15 females and 24 males) with complete preoperative and postoperative clinical information including polysomnograms were included in this study.Results: Mean apnea‐hypopnea index (AHI) was 43.9 ± 32.3 preoperatively and 21.9 ± 23.5 postoperatively and reflected a statistically significant (P < 0.001) AHI reduction of 50.9% ± 38.1%. Statistical significant reduction in daytime somnolence, as measured by Epworth Sleepiness Scale (15.6 ± 5.4 preoperatively vs. 5.7 ± 4.3 postoperatively; P < 0.001), was also achieved. No statistical significant difference was found between preoperative and postoperative body mass index (BMI) (32.9 ± 7.0 vs. 32.4 ± 7.3; P = 0.270). Surgical response, as defined by > 50% reduction in AHI and final AHI < 15 with resolution of daytime somnolence, was achieved in 21 patients (53.8%). Clinical characteristics found to be significantly different between the responders and nonresponders were BMI, AHI, and lateral velopharyngeal collapse. Patients with BMI < 30, AHI < 60, or absence of lateral velopharyngeal collapse have excellent surgical response rate of 88.2%, 67.9%, or 66.7%, respectively.Conclusions: We identified three clinical characteristics associated with increased surgical response rate. This finding may be useful for patient selection and counseling prior to surgery.Level of Evidence: 4. Laryngoscope, 125:1013–1020, 2015
- 17 December 2013
- Published by Wiley in The Laryngoscope
- Vol. 124 (8) , 1819-1826
Serum prognostic biomarkers in head and neck cancer patients
Objectives/Hypothesis A reliable estimate of survival is important as it may impact treatment choice. The objective of this study is to identify serum autoantibody biomarkers that can be used to improve prognostication for patients affected with head and neck squamous cell carcinoma (HNSCC). Study Design Prospective cohort study. Methods A panel of 130 serum biomarkers, previously selected for cancer detection using microarray‐based serological profiling and specialized bioinformatics, were evaluated for their potential as prognostic biomarkers in a cohort of 119 HNSCC patients followed for up to 12.7 years. A biomarker was considered positive if its reactivity to the particular patient's serum was greater than one standard deviation above the mean reactivity to sera from the other 118 patients, using a leave‐one‐out cross‐validation model. Survival curves were estimated according to the Kaplan‐Meier method, and statistically significant differences in survival were examined using the log rank test. Independent prognostic biomarkers were identified following analysis using multivariate Cox proportional hazards models. Results Poor overall survival was associated with African Americans (hazard ratio [HR] for death = 2.61; 95% confidence interval [CI]: 1.58‐4.33; P = .000), advanced stage (HR = 2.79; 95% CI: 1.40‐5.57; P = .004), and recurrent disease (HR = 6.66; 95% CI: 2.54‐17.44; P = .000). On multivariable Cox analysis adjusted for covariates (race and stage), six of the 130 markers evaluated were found to be independent prognosticators of overall survival. Conclusions The results shown here are promising and demonstrate the potential use of serum biomarkers for prognostication in HNSCC patients. Further clinical trials to include larger samples of patients across multiple centers may be warranted. Level of Evidence NA Laryngoscope, 124:1819–1826, 2014
- 17 December 2013
- Published by Wiley in The Laryngoscope
- Vol. 124 (8) , 1819-1826
Serum prognostic biomarkers in head and neck cancer patients
Objectives/Hypothesis A reliable estimate of survival is important as it may impact treatment choice. The objective of this study is to identify serum autoantibody biomarkers that can be used to improve prognostication for patients affected with head and neck squamous cell carcinoma (HNSCC). Study Design Prospective cohort study. Methods A panel of 130 serum biomarkers, previously selected for cancer detection using microarray‐based serological profiling and specialized bioinformatics, were evaluated for their potential as prognostic biomarkers in a cohort of 119 HNSCC patients followed for up to 12.7 years. A biomarker was considered positive if its reactivity to the particular patient's serum was greater than one standard deviation above the mean reactivity to sera from the other 118 patients, using a leave‐one‐out cross‐validation model. Survival curves were estimated according to the Kaplan‐Meier method, and statistically significant differences in survival were examined using the log rank test. Independent prognostic biomarkers were identified following analysis using multivariate Cox proportional hazards models. Results Poor overall survival was associated with African Americans (hazard ratio [HR] for death = 2.61; 95% confidence interval [CI]: 1.58‐4.33; P = .000), advanced stage (HR = 2.79; 95% CI: 1.40‐5.57; P = .004), and recurrent disease (HR = 6.66; 95% CI: 2.54‐17.44; P = .000). On multivariable Cox analysis adjusted for covariates (race and stage), six of the 130 markers evaluated were found to be independent prognosticators of overall survival. Conclusions The results shown here are promising and demonstrate the potential use of serum biomarkers for prognostication in HNSCC patients. Further clinical trials to include larger samples of patients across multiple centers may be warranted. Level of Evidence NA Laryngoscope, 124:1819–1826, 2014
- 2 April 2013
- Published by Wiley in The Laryngoscope
- Vol. 123 (7) , 1811-1816
Transoral robotic surgery for treatment of obstructive sleep apnea‐hypopnea syndrome
Objectives/Hypothesis: To evaluate the efficacy of base of tongue (BOT) resection via transoral robotic surgery (TORS) in the treatment of obstructive sleep apnea/hypopnea syndrome (OSAHS).Study Design: Case seriesMethods: Between June 2010 and May 2012, BOT resection via TORS was performed on 27 patients with OSAHS. Patients were excluded from this analysis if other concomitant upper airway procedures such as uvulopalatopharyngoplasty were performed, or if postoperative polysomnograms were not available.Results: Twelve patients who underwent BOT resection alone were included in this study. The median age for these 12 patients was 48.5 (range, 19–64) and included nine females and three males. The mean apnea‐hypopnea index (AHI) was 43.9 ± 41.1 preoperatively and 17.6 ± 16.2 postoperatively. This difference in AHI was statistically significant (P = 0.007) and reflected an average AHI reduction of 56.2 ± 28.3%. Statistical significant reductions in daytime somnolence level, as measured by Epworth Sleepiness Scale (13.7 ± 5.2 preoperatively vs. 6.4 ± 4.5 postoperatively, P P P = 0.296) or minimum oxygen saturation (83.3 ± 5.5% vs. 84.0 ± 6.4%, P = 0.680).Conclusions: This is the first study looking at the use of TORS to address obstruction at the level of BOT only, not confounded by surgical alterations at other levels of upper airway. This preliminary result on the use of BOT resection via TORS for the treatment of patients with OSAHS is encouraging and warrants further investigations.Level of Evidence: 4. Laryngoscope, 2012
- 2 April 2013
- Published by Wiley in The Laryngoscope
- Vol. 123 (7) , 1811-1816
Transoral robotic surgery for treatment of obstructive sleep apnea‐hypopnea syndrome
Objectives/Hypothesis: To evaluate the efficacy of base of tongue (BOT) resection via transoral robotic surgery (TORS) in the treatment of obstructive sleep apnea/hypopnea syndrome (OSAHS).Study Design: Case seriesMethods: Between June 2010 and May 2012, BOT resection via TORS was performed on 27 patients with OSAHS. Patients were excluded from this analysis if other concomitant upper airway procedures such as uvulopalatopharyngoplasty were performed, or if postoperative polysomnograms were not available.Results: Twelve patients who underwent BOT resection alone were included in this study. The median age for these 12 patients was 48.5 (range, 19–64) and included nine females and three males. The mean apnea‐hypopnea index (AHI) was 43.9 ± 41.1 preoperatively and 17.6 ± 16.2 postoperatively. This difference in AHI was statistically significant (P = 0.007) and reflected an average AHI reduction of 56.2 ± 28.3%. Statistical significant reductions in daytime somnolence level, as measured by Epworth Sleepiness Scale (13.7 ± 5.2 preoperatively vs. 6.4 ± 4.5 postoperatively, P P P = 0.296) or minimum oxygen saturation (83.3 ± 5.5% vs. 84.0 ± 6.4%, P = 0.680).Conclusions: This is the first study looking at the use of TORS to address obstruction at the level of BOT only, not confounded by surgical alterations at other levels of upper airway. This preliminary result on the use of BOT resection via TORS for the treatment of patients with OSAHS is encouraging and warrants further investigations.Level of Evidence: 4. Laryngoscope, 2012
- 24 September 2012
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 147 (6) , 1041-1046
Single‐Incision Transaxillary Robotic Thyroidectomy
Objective: We reviewed our initial experience with robotic thy‐roidectomy to identify challenges and limitations of this new surgical approach when applied to a North American population.Study Design: Case series.Setting: Academic institution.Subjects/Methods: Retrospective review of 18 consecutive robotic thyroid lobectomies performed from February 2010 to April 2012 involving 16 female patients. Two patients underwent robot‐assisted completion thyroidectomy a few months following the initial thyroid surgery, one for cancer and the other for goiter.Results: Median age was 47.5 years (range, 18‐62 years), and median body mass index was 28.7 (range, 19.4‐44.5). Median thyroid nodule size was 2.9 cm (range, 1.1‐4.7 cm). All but 1 case (6%) was performed successfully via single axillary incision. There was no conversion to an open approach. Median operative time was 170 minutes (range, 95‐220 minutes), and median blood loss was 12.5 mL (range, 5‐75 mL). Complications occurred in 4 cases (22%) to include temporary vocal cord pareses (n = 3) and a postoperative hematoma that required exploration. Median hospital stay was 2 days (range, 1‐3 days).Conclusion: Single‐incision transaxillary robotic thyroidectomy can be technically challenging in North American patients with a larger body frame due to difficulty in optimal placement of all 4 robotic instruments via a single axillary incision. All 3 cases of temporary vocal cord paresis occurred early in our experience and may have been due to our relative inexperience with this new approach and associated instrumentation. Other limitations include less than optimal visualization of the recurrent laryngeal nerve in the contralateral lobe as well as poor access to the substernal region.Level of Evidence: 4
- 24 September 2012
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 147 (6) , 1041-1046
Single‐Incision Transaxillary Robotic Thyroidectomy
Objective: We reviewed our initial experience with robotic thy‐roidectomy to identify challenges and limitations of this new surgical approach when applied to a North American population.Study Design: Case series.Setting: Academic institution.Subjects/Methods: Retrospective review of 18 consecutive robotic thyroid lobectomies performed from February 2010 to April 2012 involving 16 female patients. Two patients underwent robot‐assisted completion thyroidectomy a few months following the initial thyroid surgery, one for cancer and the other for goiter.Results: Median age was 47.5 years (range, 18‐62 years), and median body mass index was 28.7 (range, 19.4‐44.5). Median thyroid nodule size was 2.9 cm (range, 1.1‐4.7 cm). All but 1 case (6%) was performed successfully via single axillary incision. There was no conversion to an open approach. Median operative time was 170 minutes (range, 95‐220 minutes), and median blood loss was 12.5 mL (range, 5‐75 mL). Complications occurred in 4 cases (22%) to include temporary vocal cord pareses (n = 3) and a postoperative hematoma that required exploration. Median hospital stay was 2 days (range, 1‐3 days).Conclusion: Single‐incision transaxillary robotic thyroidectomy can be technically challenging in North American patients with a larger body frame due to difficulty in optimal placement of all 4 robotic instruments via a single axillary incision. All 3 cases of temporary vocal cord paresis occurred early in our experience and may have been due to our relative inexperience with this new approach and associated instrumentation. Other limitations include less than optimal visualization of the recurrent laryngeal nerve in the contralateral lobe as well as poor access to the substernal region.Level of Evidence: 4
- Open Access
- 13 August 2012
- Published by Hindawi Limited in Case Reports in Otolaryngology
- Vol. 2012, 1-6
A Case of Radiation-Induced Multifocal Laryngeal Angiosarcoma Presenting as a Diagnostic Dilemma
Head and neck sarcomas are relatively rare tumors, with angiosarcomas representing a small subset. Angiosarcoma is a malignant endothelial neoplasm characterized by atypical, multilayered, or solid endothelial proliferation with vasoformative architecture. The global incidence of irradiation-associated sarcoma is estimated as between 0.03% and 0.08%. Here we reported the case of an elderly woman previously treated with radiation more than 20 years ago for an unknown primary of head and neck. This interesting case presented as a diagnostic challenge, and multiple biopsies were required to eventually establish the diagnosis of laryngeal angiosarcoma. We additionally have confirmation from our prior radiation records that the patient did, in fact, receive a substantial dose of radiation to the site previously. To our knowledge, this case represents the first report of a documented radiation-induced multifocal laryngeal angiosarcoma.
- 13 August 2012
- Published by Hindawi Limited in Case Reports in Otolaryngology
- Vol. 2012, 1-6
Open AccessA Case of Radiation-Induced Multifocal Laryngeal Angiosarcoma Presenting as a Diagnostic Dilemma
Head and neck sarcomas are relatively rare tumors, with angiosarcomas representing a small subset. Angiosarcoma is a malignant endothelial neoplasm characterized by atypical, multilayered, or solid endothelial proliferation with vasoformative architecture. The global incidence of irradiation-associated sarcoma is estimated as between 0.03% and 0.08%. Here we reported the case of an elderly woman previously treated with radiation more than 20 years ago for an unknown primary of head and neck. This interesting case presented as a diagnostic challenge, and multiple biopsies were required to eventually establish the diagnosis of laryngeal angiosarcoma. We additionally have confirmation from our prior radiation records that the patient did, in fact, receive a substantial dose of radiation to the site previously. To our knowledge, this case represents the first report of a documented radiation-induced multifocal laryngeal angiosarcoma.
- 17 January 2012
- Published by Wiley in The Laryngoscope
- Vol. 122 (2) , 473-479
Lateral oropharyngeal wall and supraglottic airway collapse associated with failure in sleep apnea surgery
Objectives/Hypothesis: To identify patterns of airway collapse during preoperative drug‐induced sleep endoscopy (DISE) as predictors of surgical failure following multilevel airway surgery for patients with obstructive sleep apnea‐hypopnea syndrome (OSAHS).Study Design: Retrospective clinical chart review.Methods: Medical records of patients who underwent site‐specific surgical modification of the upper airway for treatment of OSHAS were reviewed. Patients were included in this study if they had a preoperative airway evaluation with DISE as well as preoperative and postoperative polysomnography. Airway obstruction on DISE was described according to airway level, severity, and axis of collapse. Severe airway obstruction was defined as >75% collapse on endoscopy. Surgical success was described as a postoperative apnea‐hypopnea index (AHI) of 50% decrease in preoperative AHI.Results: A total of 34 patients were included in this study. The overall surgical success rate was 56%. Surgical success (n = 19) and surgical failure (n = 15) patients were similar with regard to age, gender, body mass index, preoperative AHI, Friedman stage, adenotonsillar grades, and surgical management. DISE findings in the surgical failure group demonstrated greater incidence of severe lateral oropharyngeal wall collapse (73.3% vs. 36.8%, P = .037) and severe supraglottic collapse (93.3% vs. 63.2%, P = .046) as compared to the surgical success group.Conclusions: The presence of severe lateral pharyngeal wall and/or supraglottic collapse on preoperative DISE is associated with OSAHS surgical failure. The identification of this failure‐prone collapse pattern may be useful in preoperative patient counseling as well as in directing an individualized and customized approach to the treatment of OSHAS.
- 17 January 2012
- Published by Wiley in The Laryngoscope
- Vol. 122 (2) , 473-479
Lateral oropharyngeal wall and supraglottic airway collapse associated with failure in sleep apnea surgery
Objectives/Hypothesis: To identify patterns of airway collapse during preoperative drug‐induced sleep endoscopy (DISE) as predictors of surgical failure following multilevel airway surgery for patients with obstructive sleep apnea‐hypopnea syndrome (OSAHS).Study Design: Retrospective clinical chart review.Methods: Medical records of patients who underwent site‐specific surgical modification of the upper airway for treatment of OSHAS were reviewed. Patients were included in this study if they had a preoperative airway evaluation with DISE as well as preoperative and postoperative polysomnography. Airway obstruction on DISE was described according to airway level, severity, and axis of collapse. Severe airway obstruction was defined as >75% collapse on endoscopy. Surgical success was described as a postoperative apnea‐hypopnea index (AHI) of 50% decrease in preoperative AHI.Results: A total of 34 patients were included in this study. The overall surgical success rate was 56%. Surgical success (n = 19) and surgical failure (n = 15) patients were similar with regard to age, gender, body mass index, preoperative AHI, Friedman stage, adenotonsillar grades, and surgical management. DISE findings in the surgical failure group demonstrated greater incidence of severe lateral oropharyngeal wall collapse (73.3% vs. 36.8%, P = .037) and severe supraglottic collapse (93.3% vs. 63.2%, P = .046) as compared to the surgical success group.Conclusions: The presence of severe lateral pharyngeal wall and/or supraglottic collapse on preoperative DISE is associated with OSAHS surgical failure. The identification of this failure‐prone collapse pattern may be useful in preoperative patient counseling as well as in directing an individualized and customized approach to the treatment of OSHAS.